CORBF vs. SBC, TALK, FLGT, INNV, EHAB, CELC, DCGO, VMD, PSNL, and AIRS
Should you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include SBC Medical Group (SBC), Talkspace (TALK), Fulgent Genetics (FLGT), InnovAge (INNV), Enhabit (EHAB), Celcuity (CELC), DocGo (DCGO), Viemed Healthcare (VMD), Personalis (PSNL), and AirSculpt Technologies (AIRS). These companies are all part of the "healthcare" industry.
Global Cord Blood vs.
SBC Medical Group (NASDAQ:SBC) and Global Cord Blood (NYSE:CORBF) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking, profitability, risk and earnings.
Global Cord Blood has lower revenue, but higher earnings than SBC Medical Group.
Global Cord Blood's return on equity of 0.00% beat SBC Medical Group's return on equity.
SBC Medical Group has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of -0.29, meaning that its stock price is 129% less volatile than the S&P 500.
SBC Medical Group and Global Cord Blood both received 0 outperform votes by MarketBeat users.
In the previous week, SBC Medical Group had 4 more articles in the media than Global Cord Blood. MarketBeat recorded 4 mentions for SBC Medical Group and 0 mentions for Global Cord Blood. SBC Medical Group's average media sentiment score of 1.27 beat Global Cord Blood's score of 0.00 indicating that SBC Medical Group is being referred to more favorably in the media.
60.8% of SBC Medical Group shares are owned by institutional investors. 63.9% of SBC Medical Group shares are owned by company insiders. Comparatively, 0.5% of Global Cord Blood shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Summary
SBC Medical Group beats Global Cord Blood on 7 of the 10 factors compared between the two stocks.
Get Global Cord Blood News Delivered to You Automatically
Sign up to receive the latest news and ratings for CORBF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CORBF vs. The Competition
Global Cord Blood Competitors List
Related Companies and Tools
This page (NYSE:CORBF) was last updated on 3/4/2025 by MarketBeat.com Staff
Free CORBF Stock Alerts